26 May 2013
Keywords: Genfit, GFT505, Hepatititis, NASH, USA, FDA, Ph IIb
Article | 05 September 2012
French biotech firm Genfit (Alternext: ALGFT) says that the US Food and Drug Administration has approved the continuing development of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 September 2012
6 September 2012
24 May 2013
© 2013 thepharmaletter.com